Details for Patent: 10,322,239
✉ Email this page to a colleague
Which drugs does patent 10,322,239 protect, and when does it expire?
Patent 10,322,239 protects EVZIO, EVZIO (AUTOINJECTOR), and NALOXONE HYDROCHLORIDE (AUTOINJECTOR), and is included in three NDAs.
This patent has thirty-five patent family members in ten countries.
Summary for Patent: 10,322,239
| Title: | Medicament delivery device for administration of opioid antagonists including formulations for naloxone |
| Abstract: | Medicament delivery devices for administration of opioid antagonists are described herein. In some embodiments, an apparatus includes a housing, a medicament container disposed within the housing and an energy storage member disposed within the housing. The medicament container is filled with a naloxone composition that includes naloxone or salts thereof, a tonicity-adjusting agent, and a pH-adjusting agent, whereby the osmolality of the naloxone composition ranges from about 250-350 mOsm and the pH ranges from about 3-5. The energy storage member is configured to produce a force to deliver the naloxone composition. |
| Inventor(s): | Edwards; Eric S. (Moseley, VA), Edwards; Evan T. (Charlottesville, VA), Licata; Mark J. (Doswell, VA), Meyers; Paul F. (Fishers, IN), Blondino; Frank E. (Henrico, VA) |
| Assignee: | kaleo, Inc. (Richmond, VA) |
| Application Number: | 15/797,844 |
|
Patent Claim Types: see list of patent claims | Use; Composition; Delivery; Device; |
Drugs Protected by US Patent 10,322,239
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Kaleo Inc | EVZIO | naloxone hydrochloride | SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS | 205787-001 | Apr 3, 2014 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | USE OF A DELIVERY DEVICE TO ADMINISTER A DOSE OF NALOXONE | ⤷ Sign Up | ||||
| Kaleo Inc | EVZIO (AUTOINJECTOR) | naloxone hydrochloride | SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS | 209862-001 | Oct 19, 2016 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | USE OF A DELIVERY DEVICE TO ADMINISTER A DOSE OF NALOXONE | ⤷ Sign Up | ||||
| Kaleo Inc | NALOXONE HYDROCHLORIDE (AUTOINJECTOR) | naloxone hydrochloride | SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS | 215457-001 | Feb 28, 2022 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | USE OF A DELIVERY DEVICE TO ADMINISTER A DOSE OF NALOXONE | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 10,322,239
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2011218756 | ⤷ Sign Up | |||
| Australia | 2012211307 | ⤷ Sign Up | |||
| Australia | 2012211320 | ⤷ Sign Up | |||
| Australia | 2015255197 | ⤷ Sign Up | |||
| Brazil | 112013018807 | ⤷ Sign Up | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
